These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35554915)

  • 1. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.
    Prates ET; Garvin MR; Jones P; Miller JI; Sullivan KA; Cliff A; Gazolla JGFM; Shah MB; Walker AM; Lane M; Rentsch CT; Justice A; Pavicic M; Romero J; Jacobson D
    Methods Mol Biol; 2022; 2452():317-351. PubMed ID: 35554915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Efficacy of Molnupiravir for COVID-19 Treatment.
    Bai Y; Shen M; Zhang L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic.
    Kumar R; Harilal S; Al-Sehemi AG; Mathew GE; Carradori S; Mathew B
    Curr Med Chem; 2021; 28(15):2852-2886. PubMed ID: 32614740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
    Debnath SK; Debnath M; Srivastava R; Omri A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
    Das M; Kumar M; Jha A; Madhukiran DR; Bharti K; Mondal S; Mishra B
    Curr Drug Targets; 2021; 22(11):1232-1254. PubMed ID: 33371846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey on computational methods in discovering protein inhibitors of SARS-CoV-2.
    Liu Q; Wan J; Wang G
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34623382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-based strategies for the fight against COVID-19.
    Li H; Yuan S; Wei X; Sun H
    Chem Commun (Camb); 2022 Jul; 58(54):7466-7482. PubMed ID: 35730442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic.
    Sahoo P; Dey J; Mahapatra SR; Ghosh A; Jaiswal A; Padhi S; Prabhuswamimath SC; Misra N; Suar M
    OMICS; 2022 Sep; 26(9):473-488. PubMed ID: 36040392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
    Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
    Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19.
    Bhavaniramya S; Ramar V; Vishnupriya S; Palaniappan R; Sibiya A; Vaseeharan B
    Curr Mol Pharmacol; 2022; 15(2):393-417. PubMed ID: 34382513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic.
    Oyagbemi AA; Ajibade TO; Aboua YG; Gbadamosi IT; Adedapo ADA; Aro AO; Adejumobi OA; Thamahane-Katengua E; Omobowale TO; Falayi OO; Oyagbemi TO; Ogunpolu BS; Hassan FO; Ogunmiluyi IO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA
    J Food Biochem; 2021 Feb; 45(2):e13604. PubMed ID: 33458853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiomics integration-based molecular characterizations of COVID-19.
    Li CX; Gao J; Zhang Z; Chen L; Li X; Zhou M; Wheelock ÅM
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.
    Zhuo LS; Wang MS; Yang JF; Xu HC; Huang W; Shang LQ; Yang GF
    Top Curr Chem (Cham); 2021 Apr; 379(3):23. PubMed ID: 33886017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.